CVE-2006-1222
Multiple cross-site scripting (XSS) vulnerabilities in zeroboard 4.1 pl7 allows allow remote...
Multiple cross-site scripting (XSS) vulnerabilities in zeroboard 4.1 pl7 allows allow remote attackers to inject arbitrary web script or HTML via the (1) memo box title, (2) user email, and (3) homepage fields.
Exploit likelihood
What each source reports
NVD Score used
Multiple cross-site scripting (XSS) vulnerabilities in zeroboard 4.1 pl7 allows allow remote attackers to inject arbitrary web script or HTML via the (1) memo box title, (2) user email, and (3) homepage fields.
- Record
CVE-2006-1222- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Updated
- 2026-11-02
CVE List No score
Multiple cross-site scripting (XSS) vulnerabilities in zeroboard 4.1 pl7 allows allow remote attackers to inject arbitrary web script or HTML via the (1) memo box title, (2) user email, and (3) homepage fields.
- Record
CVE-2006-1222- Updated
- 2026-11-02
EUVDEUVD-2006-1226 No score
Multiple cross-site scripting (XSS) vulnerabilities in zeroboard 4.1 pl7 allows allow remote attackers to inject arbitrary web script or HTML via the (1) memo box title, (2) user email, and (3) homepage fields.
- Record
EUVD-2006-1226- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-7fmh-jvgj-xpmw No score
Multiple cross-site scripting (XSS) vulnerabilities in zeroboard 4.1 pl7 allows allow remote...
Multiple cross-site scripting (XSS) vulnerabilities in zeroboard 4.1 pl7 allows allow remote attackers to inject arbitrary web script or HTML via the (1) memo box title, (2) user email, and (3) homepage fields.
- Record
GHSA-7fmh-jvgj-xpmw- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2006-1222 is a medium vulnerability (CVSS 4.3) in Zeroboard, published March 14, 2006. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.80%, the 78th percentile. No source names a fixed version.